Carpenter Technology Corporation
CRS
$377.09
-0.91%
Carpenter Technology Corporation is a specialty metals producer that manufactures high-performance alloys, stainless steels, and engineered products — including powder metals and additive manufacturing feedstock — for aerospace and defense, medical, energy, transportation, and industrial end markets, operating primarily through its Specialty Alloys Operations (SAO) and Performance Engineered Products segments. The company occupies a differentiated, high-value niche within the broader steel industry, positioning itself less as a commodity mill and more as a mission-critical supplier of premium alloys where qualification cycles and specification lock-in create durable competitive moats. The current investor narrative centers on a powerful aerospace-driven earnings upcycle — quarterly revenue reached $851 million with 12.6% year-over-year growth and net margin expanded to 19.1% — alongside aggressive capital return through buybacks and a balance sheet deleveraging story. However, the debate has shifted sharply: after a spectacular run that lifted shares roughly 58% over the past year, the stock has corrected more than 32% in three months, forcing investors to weigh whether the margin-expansion story is structurally intact or whether peak-cycle pricing and premium valuation leave little room for error.…
CRS
Carpenter Technology Corporation
$377.09
Related headlines
Investment Opinion: Should I buy CRS Today?
Rating: Hold. The core thesis is that CRS is a high-quality specialty-alloy franchise with genuine structural margin improvement, but the current valuation and broken technical trend offer an unfavorable risk/reward at $377.09 despite the 'strong buy' consensus and $536.25 average target price implying 42% upside. The stock has already fallen 32.39% in three months, and investors should wait for evidence of a base before committing new capital.
Supporting evidence for the Hold is mixed but tilts toward patience. On the positive side, revenue grew 12.63% year-over-year to $851.0 million, net margin expanded to 19.08% from 12.42% a year earlier, ROE is 23.78%, free cash flow TTM is $362.3 million, and debt-to-equity is only 0.31. However, the trailing PE of 58.25x, PS of 9.87x, and EV/EBITDA of 37.02x are far above steel-industry norms, and the forward PE of 23.65x depends on EPS more than doubling to $22.30. The 42% upside to the average target is compelling, but the 44% spread between the $430 low and $620 high targets shows that conviction is not uniform.
The biggest risks that could invalidate the thesis are a plateau in aerospace demand (66% of revenue), margin mean-reversion from 19% toward the 12-14% range of 2024-2025, and further multiple compression from 23.65x forward PE. This Hold would upgrade to Buy if the stock stabilizes above $400 and forward EPS estimates hold at $22.30 or rise, or if the forward PE compresses below 20x on sustained margins. It would downgrade to Sell if revenue growth decelerates below 10% or net margin falls below 15%. On balance, the stock is fairly valued to slightly overvalued relative to its own history and clearly overvalued relative to peers, but the quality of the franchise and the analyst support argue against selling into the drawdown.
Sign up to view all
CRS 12-Month Price Forecast
CRS presents a genuine quality-versus-price dilemma: the fundamental trajectory is excellent, with 12.63% revenue growth, 19.08% net margin, 23.78% ROE, and $362.3 million of TTM free cash flow, but the valuation at 58.25x trailing PE and 37.02x EV/EBITDA already discounts much of that success. The 32.39% three-month decline and -35.08% relative strength suggest the market is repricing the premium multiple even as analysts maintain a 'strong buy' and a $536.25 average target. The forward PE of 23.65x is the key anchor: if EPS of $22.30 materializes, the stock is reasonably valued, but that requires the current margin run-rate to persist. I would upgrade to bullish if the stock reclaims $400 and forward EPS estimates hold or rise, and downgrade to bearish if net margin falls below 15% or revenue growth decelerates below 10%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Carpenter Technology Corporation's 12-month outlook, with a consensus price target around $536.25 and implied upside of +42.2% versus the current price.
Average Target
$536.25
0 analysts
Implied Upside
+42.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$430 - $620
Analyst target range
Coverage is robust, with 8 analysts and a consensus recommendation of "strong buy" (mean rating of 1.375 on a 1-to-5 scale where 1 is a strong buy). The average target price of $536.25 implies roughly 42% upside from the current $377.09 — a striking gap that highlights how far the stock has fallen below the Street's fair-value estimates. Consensus revenue estimates of $4.73 billion and EPS estimates averaging $22.30 (range $21.28 to $23.49) suggest analysts expect the current earnings run-rate to persist, and the bullish consensus stands in sharp contrast to the stock's recent price action, implying the market is discounting something the analysts are not.
The target range of $430 to $620 is wide — a 44% spread from low to high — signaling meaningful uncertainty about the durability of the aerospace upcycle and margin sustainability. The high target of $620 assumes multiple expansion back toward prior peaks and continued aero-driven earnings growth, while even the low target of $430 sits 14% above the current price, meaning every analyst sees upside. Institutional ratings show a stable-to-positive pattern: JP Morgan, KeyBanc, TD Cowen, BTIG, and Susquehanna have all reiterated Overweight/Buy/Positive ratings through mid-2026, with Wells Fargo the lone Equal Weight. The absence of downgrades despite a 32% drawdown suggests analysts view the selloff as a valuation reset rather than a fundamental deterioration — but the wide dispersion and the stock's failure to hold anywhere near the average target indicate that conviction, while broad, is not yet being validated by price action.
Bulls vs Bears: CRS Investment Factors
The bull case rests on genuinely impressive fundamentals: 12.63% revenue growth, a 660 basis point net margin expansion over six quarters, 23.78% ROE, and a fortress balance sheet with 0.31 debt-to-equity. The bear case rests on valuation and price action: a 58.25x trailing PE near historical peaks, 37.02x EV/EBITDA versus single-digit industry norms, and a 32.39% three-month decline that has broken the intermediate-term trend. On balance, the fundamental evidence is stronger than the technical evidence, but the valuation evidence is the most decisive single factor. The most important tension is whether the current 19% net margin is a structural new normal for CRS's specialty-alloy franchise or a cyclical peak in an aerospace upcycle; if margins hold, the forward PE of 23.65x is reasonable, but if they mean-revert toward the 12-14% levels of 2024-2025, the stock is materially overvalued even after the drawdown.
Bullish
- Aerospace-driven revenue acceleration: Revenue reached $851.0 million in the June 2026 quarter, up 12.63% year-over-year and marking the third consecutive sequential increase from $728.0 million in December 2025 and $811.5 million in March 2026. Aerospace and defense generated $558.1 million, or roughly 66% of the total, positioning CRS directly in the strongest end market for specialty alloys.
- Structural margin expansion: Net margin expanded to 19.08% in the June 2026 quarter from 14.46% in December 2025 and 12.42% in December 2024, a roughly 660 basis point improvement over six quarters. Gross margin climbed to 31.61% from 26.22% a year earlier, and operating margin reached 24.32%, reflecting premium alloy mix and pricing power rather than one-off gains.
- Strong balance sheet and cash generation: Debt-to-equity is a conservative 0.31, the current ratio is 3.81, and interest coverage is 34.5x, leaving ample financial flexibility. Free cash flow TTM is $362.3 million, with the June quarter alone generating $155.0 million of FCF on $240.1 million of operating cash flow against $85.1 million of capex, a 2.82x capex coverage ratio.
- Analyst consensus and target upside: Eight analysts carry a consensus recommendation of 'strong buy' (mean rating 1.375), with an average target price of $536.25 implying roughly 42% upside from the current $377.09. Even the low target of $430 sits 14% above the current price, and no downgrades have emerged despite the 32% three-month drawdown.
Bearish
- Extreme valuation versus history and peers: The trailing PE of 58.25x is near the top of CRS's own historical band, up from 14.3x in June 2024 and 30.98x in June 2025, while the PS ratio has expanded from 6.70x to 9.87x and price-to-book from 3.28x to 13.85x. EV/EBITDA of 37.02x is far above the single-digit multiples typical for steel and basic materials producers, embedding near-flawless execution.
- Severe technical breakdown: The stock is down 32.39% over three months and 15.39% over six months, trading at just 36.7% of its 52-week range of $233.78 to $625.99. Relative strength versus the S&P 500 is -35.08% over three months and -9.65% over one month, with no evidence of capitulation given a short ratio of only 1.66 days-to-cover.
- Aerospace concentration risk: Aerospace and defense accounted for $558.1 million, or roughly 66%, of the $851 million quarterly revenue, dwarfing industrial and consumer at $117.4 million and medical at $67.4 million. Any plateau in aerospace build rates or aftermarket demand would disproportionately hit CRS's growth and margin story.
- Forward earnings dependency: The forward PE of 23.65x versus trailing PE of 58.25x implies the market expects EPS to more than double to the consensus $22.30 from the trailing run-rate. This leaves the stock highly sensitive to any earnings disappointment, and the PEG ratio of 1.41 offers only modest compensation for that execution risk.
CRS Technical Analysis
Carpenter Technology is in a clear intermediate-term downtrend that stands in stark contrast to its powerful longer-term uptrend. The stock is up 58.36% over the past year but has fallen 32.39% over three months and 15.39% over six months, and at $377.09 it trades at just 36.7% of its 52-week range of $233.78 to $625.99 — a dramatic collapse from the highs. This positioning near the lower third of the annual range signals that momentum has decisively broken; the stock is no longer an extended momentum name but a falling knife in search of a base, with the 52-week low roughly 38% below current levels as the ultimate downside reference.
Short-term momentum confirms the deterioration rather than hinting at stabilization. The stock is down 8.43% over the past month versus a gain of 1.22% for the S&P 500, producing a relative strength of -9.65%, and the three-month relative strength of -35.08% is even more punishing. This is not a divergence between short- and long-term trends but a consistent, accelerating unwind: the 1-month decline (-8.43%) compounds the 3-month decline (-32.39%), and the year-to-date gain of just 11.45% has nearly converged with the S&P 500's 11.93%, erasing almost all of the stock's 2026 outperformance. With volume of roughly 507,000 shares and a short ratio of 1.66 days-to-cover, there is no evidence of capitulation or short-squeeze dynamics that would mark a durable bottom.
Key technical levels are well defined. Resistance sits at the 52-week high of $625.99, but the more relevant near-term barrier is the $400–$420 zone where the stock repeatedly stalled in September; a reclaim of $400 would be the first sign of stabilization, while a breakout above $625.99 would require a 66% rally and signal a full trend reversal. Support rests at the 52-week low of $233.78, with the $375–$380 area now being tested as the stock closed at $377.09. With a beta of 1.289, the stock is roughly 29% more volatile than the market, and a max drawdown of -39.11% over the period underscores the position-sizing risk — this is a high-beta cyclical where a breakdown below $375 could quickly target the $340s, while volatility of this magnitude also means sharp reflex rallies are possible.
Beta
1.29
1.29x market volatility
Max Drawdown
-39.1%
Largest decline past year
52-Week Range
$240-$626
Price range past year
Annual Return
+58.4%
Cumulative gain past year
| Period | CRS Return | S&P 500 |
|---|---|---|
| 1m | -8.4% | +0.2% |
| 3m | -32.4% | +2.9% |
| 6m | -15.4% | +8.4% |
| 1y | +58.4% | +14.9% |
| ytd | +11.5% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRS Fundamental Analysis
Carpenter's revenue trajectory is unambiguously strong and accelerating. The most recent quarter (June 2026) delivered $851.0 million in revenue, up 12.63% year-over-year, and the sequential progression tells a compelling story: $728.0 million in December 2025, $811.5 million in March 2026, and $851.0 million in June 2026 — three consecutive quarters of growth. Segment data reveals the engine: aerospace and defense markets generated $558.1 million, or roughly 66% of the $851 million total, dwarfing industrial and consumer ($117.4 million), medical ($67.4 million), energy ($56.1 million), transportation ($30.1 million), and distribution ($21.9 million). This concentration in aero — where build rates and aftermarket demand remain robust — is both the growth driver and the key risk if aerospace demand plateaus.
Profitability has expanded dramatically and consistently. Net income reached $162.4 million in the June 2026 quarter on a 19.08% net margin, up from $105.3 million (14.46% margin) in December 2025 and $84.1 million (12.42% margin) in December 2024 — a roughly 660 basis point margin expansion over six quarters. Gross margin climbed to 31.61% from 29.99% sequentially and 26.22% a year earlier, while operating margin reached 24.32% versus 21.32% in the prior quarter. EBITDA of $250.4 million (29.42% EBITDA margin) and interest coverage of 34.5x reflect a business that has moved from cyclical trough profitability to genuine structural margin expansion, likely driven by premium alloy mix, pricing power, and operating leverage on higher volumes.
Balance sheet and cash flow metrics are solid but reveal the capital intensity of the model. Debt-to-equity is a conservative 0.31, the current ratio is a robust 3.81, and ROE stands at 23.78% with ROA of 11.87% — strong returns for a capital-intensive metals producer. Free cash flow TTM is $362.3 million, and the June quarter alone generated $155.0 million of FCF on $240.1 million of operating cash flow against $85.1 million of capex, a 2.82x capex coverage ratio. The company returned capital aggressively — $45.2 million of buybacks in the June quarter and $52.7 million in March — while still growing cash to $393.3 million. The one caution flag is working capital: inventory days of 127 and a cash conversion cycle of 153 days tie up capital, and the $50.98 price-to-cash-flow ratio shows the market is paying dearly for that cash generation.
Quarterly Revenue
$851000000.0B
2026-06
Revenue YoY Growth
+12.6%
YoY Comparison
Gross Margin
31.6%
Latest Quarter
Free Cash Flow
$362300000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRS Overvalued?
Because Carpenter is solidly profitable — net income of $162.4 million in the latest quarter and positive EPS — the PE ratio is the appropriate primary metric. The trailing PE of 58.25x is extremely rich, but the forward PE of 23.65x tells the real story: the market expects earnings to more than double, consistent with consensus EPS estimates of $22.30 versus the trailing figure implied by the 58x multiple. That enormous trailing-to-forward gap signals the market is pricing in a full year of the current margin run-rate and then some, leaving the stock highly sensitive to any earnings disappointment. The PEG ratio of 1.41 and EV/EBITDA of 37.02x further confirm that expectations are elevated relative to growth.
Against its industry, Carpenter trades at a steep premium that requires justification. The PS ratio of 9.87x, price-to-book of 13.85x, and EV/EBITDA of 37.02x are far above what is typical for steel and basic materials producers, where single-digit EV/EBITDA multiples are the norm. The premium is defensible on quality grounds — a 30.58% gross margin, 22.47% operating margin, and 16.96% net margin are exceptional for the steel industry and reflect the specialty-alloy, aerospace-qualified nature of the business rather than commodity steel economics. Still, a 37x EV/EBITDA multiple embeds near-flawless execution, and the 50.98x price-to-cash-flow ratio suggests investors are paying for growth that must materialize to validate the price.
Historical context is the most damning part of the valuation case. Carpenter's own PE history shows a dramatic re-rating: 14.3x in June 2024, 23.6x in September 2024, 30.98x in June 2025, and now 58.25x trailing — with the PS ratio expanding from 6.70x in June 2024 to 9.87x today and price-to-book from 3.28x to 13.85x. The stock is near the very top of its own historical valuation band on every measure, meaning the market has already priced in years of optimistic expectations. Combined with the 32% three-month drawdown, this suggests the de-rating has begun: the market is repricing a premium multiple downward even as fundamentals remain strong, a classic setup where valuation compression can overwhelm earnings growth.
PE
58.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 14x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
37.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the durability of CRS's margin expansion and its working capital intensity. Net margin reached 19.08% in the June 2026 quarter, up roughly 660 basis points from 12.42% in December 2024, but this level is unprecedented for the company and could compress if premium alloy pricing softens or mix shifts back toward industrial products. Inventory days of 127 and a cash conversion cycle of 153 days mean a demand slowdown would tie up cash and risk write-downs, while the 50.98x price-to-cash-flow ratio leaves little valuation cushion if FCF of $362.3 million TTM fails to grow. Revenue concentration is the single largest operational vulnerability: aerospace and defense at $558.1 million represents roughly 66% of the $851 million quarterly total, so a plateau in build rates or aftermarket demand would hit both growth and margins simultaneously.
Market and competitive risks are dominated by valuation compression. At 58.25x trailing PE, 9.87x PS, 13.85x price-to-book, and 37.02x EV/EBITDA, CRS trades at a steep premium to steel and basic materials peers where single-digit EV/EBITDA multiples are typical; the premium is defensible on quality but leaves the stock exposed to any de-rating. The beta of 1.289 means the stock is roughly 29% more volatile than the market, amplifying sector rotation out of high-multiple cyclicals. The 32.39% three-month decline and -35.08% relative strength versus the S&P 500 already show this de-rating in progress, and the wide analyst target range of $430 to $620 (a 44% spread) signals genuine uncertainty about the aerospace upcycle's durability. Recent news flow is sparse and indirect, but the broader theme of cyclicality and valuation concerns in basic materials names reinforces the risk that premium multiples are being questioned sector-wide.
In a worst-case scenario, aerospace demand plateaus, premium alloy pricing rolls over, and net margin mean-reverts toward the 12-14% range of 2024-2025, causing consensus EPS of $22.30 to be cut materially. Combined with multiple compression from 23.65x forward toward the historical 14-24x band, the stock could retest its 52-week low of $233.78, which is roughly 38% below the current $377.09. The max drawdown of -39.11% over the observed period provides a concrete historical reference for how far this high-beta name can fall in an adverse cycle. An investor buying today could lose approximately 38% in this scenario, and a break below the $375-$380 support zone would likely accelerate selling toward the $340s before the 52-week low comes into play.
FAQ
The most severe risk is aerospace concentration: 66% of the $851 million quarterly revenue comes from aerospace and defense, so a build-rate plateau would hit both growth and margins. Second is margin mean-reversion — net margin of 19.08% is unprecedented versus 12.42% in December 2024, and a return toward 15% would break the forward EPS thesis. Third is valuation compression: at 58.25x trailing PE and 37.02x EV/EBITDA, the stock is exposed to de-rating, already visible in the 32.39% three-month decline and -35.08% relative strength. Fourth is working capital intensity, with inventory days of 127 and a 153-day cash conversion cycle that could squeeze cash flow in a slowdown. Ranked by severity: aerospace concentration, margin mean-reversion, valuation compression, then working capital.
The 12-month forecast has three scenarios: a 25% probability bull case targeting $536.25-$620 (analyst average to high target), a 50% probability base case targeting $430-$536.25 (analyst low to average), and a 25% probability bear case targeting $233.78-$377.09 (52-week low to current price). The base case is most likely, assuming revenue near the $4.73 billion consensus, EPS around $22.30, and net margins holding in the 16-19% range, with the stock grinding back toward the low end of the analyst range as the technical downtrend stabilizes. The key assumption is that the 19% net margin is structural rather than cyclical; if it holds, the 23.65x forward PE is supportable, but if it reverts, the bear case dominates.
CRS is overvalued relative to its own history and to steel-industry peers, though the forward multiple is more reasonable. The trailing PE of 58.25x compares with 14.3x in June 2024 and 30.98x in June 2025, while PS of 9.87x and price-to-book of 13.85x are near the top of the historical band. EV/EBITDA of 37.02x is far above the single-digit multiples typical for basic materials producers, though the 30.58% gross margin and 22.47% operating margin justify some quality premium. The forward PE of 23.65x implies the market expects EPS to more than double to $22.30, so the valuation is fair only if that earnings growth materializes. The market is paying a premium for a specialty-alloy franchise, not a commodity mill, but the margin of safety is thin.
From a risk/reward perspective, CRS is a Hold rather than a compelling buy at $377.09. The analyst average target of $536.25 implies 42% upside, and the 'strong buy' consensus of 1.375 reflects confidence in the aerospace-driven margin story, but the stock is down 32.39% over three months and sits at just 36.7% of its 52-week range, with no technical evidence of a bottom. The biggest downside risk is a retest of the $233.78 52-week low, roughly 38% below the current price, if margins mean-revert. CRS is a good buy for long-term investors who believe 19% net margins are structural and who can tolerate beta of 1.289, particularly on a stabilization above $400; it is not a good buy for short-term traders catching a falling knife.
CRS is better suited to long-term holding than short-term trading. The stock is in a clear intermediate-term downtrend (-32.39% over three months, -8.43% over one month) with beta of 1.289 and a max drawdown of -39.11%, making short-term entry timing difficult and risky. The growth story — 12.63% revenue growth, 660 basis points of margin expansion, 23.78% ROE — requires time to be validated and for the market to regain confidence in the premium multiple. The negligible 0.13% dividend yield provides no income support, so returns depend entirely on capital appreciation. A suggested minimum holding period is 18-24 months, allowing at least four to six quarters of earnings to confirm whether 19% net margins are sustainable and for the valuation to normalize.